Related Experiment Videos
Metabolic activation of toxins: tissue-specific expression and metabolism in target organs
1Department of Pharmacology and Toxicology, University of Oulu, Finland. olavi.pelkonen@oulu.fi
Abstract:
Cytochrome P450 (CYP) enzymes catalyze the generation of reactive species capable of binding with cellular macromolecules, leading to acute and delayed toxicity. Since individual CYP forms differ markedly in their substrate preferences and regulation, the expression profiles of CYP in various cell types are important determinants in tissue-specific toxicity. The highest concentrations of most forms of CYP are found in liver, but they are also present in many extrahepatic organs. Liver is also a target organ in which CYP-mediated activation and toxic outcome have been most convincingly linked. Prime examples are paracetamol-induced hepatotoxicity and aflatoxin B1-associated hepatic cancer. In contrast to liver, most extrahepatic tissues are composed of multiple call types, which make experimental approaches difficult. Also the low abundance of individual forms is a challenge in the study of extrahepatic CYP-related toxicity. Recent years have witnessed the emergence of molecular biological techniques, e.g., reverse transcriptase-polymerase chain reactions, which facilitate the study of low abundant CYP forms in human tissues. Nevertheless, in the end we need definite information on the expression of activity, and for this purpose enzyme-specific substrates, reactions, and inhibitors and other methods to detect proteins and associated activities are needed. In humans, it is important to measure activities of specific enzymes in vivo. For this purpose, two approaches are currently available. Metabolism and/or elimination of enzyme-specific drugs can be employed. In cases in which genetic background determines the presence or absence of a specific enzyme, phenotyping and genotyping tests can be devised, e.g., for CYP2D6 (debrisoquine hydroxylation) polymorphism.
Insights
Cytochrome P450 (CYP) enzymes can cause toxicity by generating reactive species. Understanding CYP expression in different tissues is crucial for predicting and studying tissue-specific toxicity, especially in extrahepatic organs.
Area of Science:
- Biochemistry
- Toxicology
- Molecular Biology
Background:
- Cytochrome P450 (CYP) enzymes generate reactive species, contributing to acute and delayed toxicity.
- Tissue-specific toxicity is influenced by the expression profiles and regulation of individual CYP forms.
- While liver has high CYP concentrations and is a key target organ (e.g., paracetamol hepatotoxicity), extrahepatic organs also contain CYPs but present experimental challenges due to cellular diversity and low abundance of specific forms.
Purpose of the Study:
- To highlight the importance of CYP expression profiles in determining tissue-specific toxicity.
- To discuss the challenges in studying extrahepatic CYP-related toxicity.
- To emphasize the need for methods to assess CYP activity in vivo.
Main Methods:
- Utilizing molecular biological techniques like reverse transcriptase-polymerase chain reactions to study low-abundance CYP forms.
- Employing enzyme-specific substrates, reactions, and inhibitors to detect CYP proteins and activities.
- Measuring in vivo CYP activities through drug metabolism/elimination studies and phenotyping/genotyping tests (e.g., for CYP2D6 polymorphism).
Main Results:
- CYP enzymes are present in both liver and extrahepatic organs, influencing toxicity.
- Molecular techniques facilitate the study of low-abundance CYP forms in human tissues.
- In vivo methods, including drug metabolism studies and genetic tests, are essential for assessing specific CYP activities.
Conclusions:
- Understanding CYP expression and activity is critical for predicting and mitigating tissue-specific toxicity.
- Advanced molecular and in vivo techniques are necessary to overcome challenges in studying extrahepatic CYPs.
- Accurate assessment of CYP function in humans is vital for toxicological and pharmacological applications.